ROME and MILAN, Jan. 14, 2025 /PRNewswire/ -- Enea TECH and Biomedical Foundation announces a €15 million investment in Tethis S.p.A., a Milan-based company at the forefront of cancer diagnostics. Tethis is developing innovative solutions for liquid biopsy, a non-invasive blood test that...
Read More Details
Finally We wish PressBee provided you with enough information of ( Enea TECH and Biomedical Foundation invests €15 million in Tethis to develop new diagnostic methods in oncology using liquid biopsy )
Also on site :
- Born on One of These 4 Dates? You're a Wise, Old Soul
- Tony-Nominated Actress, 23, Makes Bold Declaration About Taylor Swift
- Blake Lively Wins Legal Battle Against Justin Baldoni